Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Clinical Trials
Return to: PBR Home | Contract Research & Services | Clinical Trials
Search Refinements
Search Results: Clinical Trials
1-15 of 5034 results
Novartis, MMV begin patient trial of antimalarial compound in Africa
By PBR Staff Writer
Novartis and Medicines for Malaria Venture (MMV) have started a patient trial of antimalarial compound, KAF156, in Africa.
Contract Research & Services > Clinical Trials > News
US DOD to commence new trial with Pluristem's PLX-R18 cell therapy against ARS
Pluristem Therapeutics stated that a pilot study of its PLX-R18 cell therapy will be initiated by the US Department of Defense’s (DOD) Armed Forces Radiobiology Research Institute (AFRRI), part of the Uniformed Services University of Health Sciences (USU).
Contract Research & Services > Clinical Trials > News
Mateon’s ovarian cancer treatment CA4P shows favorable results in Focus study
By PBR Staff Writer
Mateon Therapeutics’ ovarian cancer treatment CA4P in combination with Roche’s bevacizumab (Avastin) has showed favorable results in the scheduled interim analysis of the ongoing phase 2/3 Focus study.
Contract Research & Services > Clinical Trials > News
Aradigm gets NIH grant for Linhaliq in pulmonary non-tuberculous mycobacteria treatment
The National Institute of Allergy and Infectious Diseases (NIAID) and National Institutes of Health (NIH) have awarded a Small Business Initiative Research (SBIR) grant to Aradigm to study the treatment of two pulmonary non-tuberculous mycobacteria (PNTM) infections, Mycobacterium avium and Mycobacterium abscessus, with the company’s inhaled liposomal ciprofloxacin products Linhaliq and Lipoquin.
Contract Research & Services > Clinical Trials > News
FDA lifts clinical hold on study of Multikine for head and neck cancer
By PBR Staff Writer
The US Food and Drug Administration (FDA) has lifted the clinical hold it had imposed on the CEL-SCI and Ergomed co-developed Multikine’s phase 3 head and neck cancer study.
Contract Research & Services > Clinical Trials > News
BMS’ kidney cancer drug met co-primary endpoint in CheckMate trial
By PBR Staff Writer
Bristol-Myers Squibb’s (BMS) kidney cancer drug Opdivo in combination with Yervoy (ipilimumab) has met the co-primary endpoint of objective response rate (ORR) against sunitinib in CheckMate -214 trial.
Contract Research & Services > Clinical Trials > News
Ophthotech’s wet-AMD drug Fovista fails in phase 3 AMD trial
By PBR Staff Writer
Ophthotech’s anti-PDGF therapy Fovista (pegpleranib) for treating wet age-related macular degeneration (AMD) has failed to meet the primary endpoint in a phase 3 trial.
Contract Research & Services > Clinical Trials > News
Heron initiates phase 3 program for HTX-011 in postoperative pain
Heron Therapeutics has reported positive outcome of a recent End-of-Phase 2 meeting with the US Food and Drug Administration (FDA) regarding its investigational agent, HTX-011, to prevent postoperative pain for the first 72 hours post surgery.
Contract Research & Services > Clinical Trials > News
Allegro’s Luminate succeeds in phase 2 diabetic macular edema trial
By PBR Staff Writer
Allegro Ophthalmics' Luminate integrin peptide therapy has passed a phase 2 trial in diabetic macular edema (DME) patients by meeting its primary endpoint when used as a sequential treatment.
Contract Research & Services > Clinical Trials > News
Cancer Research UK, Biotecnol to begin trials of novel immuno-oncology treatment
By PBR Staff Writer
Cancer Research UK has collaborated with Biotecnol to start early phase clinical trials for new immuno-oncology treatment, Tb535H.
Contract Research & Services > Clinical Trials > News
Zynerba’s cannabis-based epilepsy gel fails in phase 2 trial
By PBR Staff Writer
Zynerba Pharmaceuticals has reported that its cannabis-based epilepsy gel ZYN002 (cannabidiol [CBD] gel) has failed to meet the primary point in a phase 2 clinical trial.
Contract Research & Services > Clinical Trials > News
Lilly’s migraine drug Lasmiditan succeeds in second phase 3 trial
By PBR Staff Writer
Eli Lilly's migraine drug Lasmiditan has met its primary endpoint in a second phase 3 trial.
Contract Research & Services > Clinical Trials > News
Orbsen gets European approval to start diabetic kidney disease trial for Obrcel-M
Orbsen Therapeutics’ stromal cell immunotherapy, OBRCEL-M has been approved to begin testing in a randomised, double blind, and placebo-controlled clinical trial in Europe to treat diabetic kidney disease.
Contract Research & Services > Clinical Trials > News
Flex Pharma launches ALS phase 2 study with FLX-787 in US
Flex Pharma has initiated a Phase 2 randomized, controlled, double-blinded, parallel design trial in the US.
Contract Research & Services > Clinical Trials > News
Merck, Generex to assess Keytruda in combination with AE37
Generex Biotechnology's subsidiary, Antigen Express has signed a clinical trial collaboration agreement with Merck, via a wholly-owned subsidiary, to assess Antigen’s AE37 cancer vaccine in combination with Merck’s anti-PD-1 (programmed death receptor-1) therapy, KEYTRUDA (pembrolizumab), in patients with metastatic triple-negative breast cancer.
Contract Research & Services > Clinical Trials > News

PBR Supplier Recommendations

CTL Laboratories - Contract Immune Monitoring and Research
Cellular Technology Limited (CTL), headquartered in Shaker Heights, OH, is a privately held biotechnology company that built its reputation as the global leader in the ELISPOT field over the past two decades by establishing the ELISPOT instrumentation and scientific principles that have helped to define the parameters of ELISPOT research for monitoring of Cell-Mediated Immunity.... Contract Research & Services > Clinical Trials > Suppliers
CRFweb... from Clindox, Suppliers of Clinical Trial Software
CRFweb is the groundbreaking eCRF application brought to you by Clindox. It sets new standards in web-based, clinical trial software. The combination of a comprehensive feature set, incredibly quick set-up time, simplicity of use and flexible pricing means no trial is too large or too small to be practical. The whole process is genuinely DIY, allowing trial managers to really take control of their trial. ... Contract Research & Services > Clinical Trials > Suppliers
LABORATORIOS INIBSA - Pharmaceutical Contract Manufacturing Company
LABORATORIOS INIBSA is a pharmaceutical contract manufacturing company. We have more than 60 years' experience and belong to the INIBSA GROUP. INIBISA supplies products and services to Biotools, Inibsa Dental and Inibsa Hospital, as well as other pharmaceutical companies through our contract manufacturing division. From our facilities in Lliçà de Vall, 20km from Barcelona LABORATORIOS INIBSA currently supplies more than 50 countries worldwide.... Contract Research & Services > Clinical Trials > Suppliers
Vaisala - Supplier of Continuous Monitoring Systems for Controlled Life Science Environments
Vaisala is a world leader in environmental and industrial measurement systems and instrumentation. We offer measurement instrumentation, continuous monitoring systems and validation systems to measure and supervise environmental conditions, within regulated or controlled life science environments.... Contract Research & Services > Clinical Trials > Suppliers
Quintiles - Bringing People and Knowledge Together for a Healthier World
Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment.... Contract Research & Services > Clinical Trials > Suppliers
See more

PBR White Paper Recommendations

Cellular Technology Limited: A multicolor Natural Killer cell-mediated cytotoxicity detection By CTL Laboratories
A multicolor Natural Killer cell-mediated cytotoxicity detection using fluorescence and direct cell imaging.... Contract Research & Services > Clinical Trials > White Papers Softigel introduces new energy gummies at vitafoods By Softigel pbr
Who hasn´t needed a wake-me-up in the morning or hasn´t dragged a tired body to the end of the day? Regardless how we individually spend our day, the intensity of our routine, the sports practice or the stressful of our labor; the common consequence is the high demand and lack of energy.... Contract Research & Services > Clinical Trials > White Papers A Survival Guide to Temperature Data in Life Sciences, by Almac By Almac
Regulations continue to evolve globally within the distribution arena of the Life Sciences industry. Good Distribution Practice of Medicinal Products for Human Use (2013/C 343/01)1 as well as Good Distribution Practices Supply Chain Integrity2 has made the most significant impact. There is an increased focus on companies being able to prove the quality and integrity of their drug product throughout the entire supply chain. The industry is facing stricter compliance demands from regulations and regulatory agencies are not always given clear guidance.... Contract Research & Services > Clinical Trials > White Papers Almac: Changing the Dynamics of Temperature Controlled Shipping Solutions By Almac
In the typical clinical trial today, the cost of shipping and distributing supplies accounts for approximately 60 percent of the overall clinical supply chain. And when the cost of product spoilage from temperature excursions is added into the mix, it is no wonder that pharmaceutical companies, Clinical Research Organizations (CROs), and logistics vendors are all eagerly searching for efficiencies and ways to carve costs out of the process.... Contract Research & Services > Clinical Trials > White Papers Almac Explores Interactive Response Technology: An Untapped Source of Historical and Real-Time Data for Risk-Based Monitoring By Almac
Risk-based monitoring has attracted the support of a diverse group of organisations in recent years. Regulators have released guidance encouraging the use of risk-based approaches to clinical trial quality, vendors have created technologies to support such methods, and large pharma companies have pooled their resources to drive adoption. Yet, despite this flurry of activity, the industry has overlooked a potentially useful source of real-time and historical data.... Contract Research & Services > Clinical Trials > White Papers See more
1-15 of 5034 results